Skip to content
10-Q

Quarterly Report

Verona Pharma plc

0001657312-25-000026

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 727.22M sh
Shares Diluted Q2 2025 · Jun 30, 2025 682.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 648.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 646.96M sh
Capex Q2 2025 · Jun 30, 2025 $535K
Capex Q2 2025 · Jun 30, 2024 $45K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $19M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.71M
Long Term Debt Q2 2025 · Jun 30, 2025 $242.43M
Long Term Debt Q2 2025 · Dec 31, 2024 $120.34M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $438.02M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $399.76M
Stockholders Equity Q2 2025 · Jun 30, 2025 $278.27M
Stockholders Equity Q2 2025 · Mar 31, 2025 $226.6M
Stockholders Equity Q2 2025 · Dec 31, 2024 $204.56M
Stockholders Equity Q2 2025 · Jun 30, 2024 $168.27M
Stockholders Equity Q2 2025 · Mar 31, 2024 $224.99M
Stockholders Equity Q2 2025 · Dec 31, 2023 $249.28M
Current Liabilities Q2 2025 · Jun 30, 2025 $51.24M
Current Liabilities Q2 2025 · Dec 31, 2024 $42.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $294.6M
Total Liabilities Q2 2025 · Dec 31, 2024 $269.68M
Current Assets Q2 2025 · Jun 30, 2025 $548.85M
Current Assets Q2 2025 · Dec 31, 2024 $453.57M
Total Assets Q2 2025 · Jun 30, 2025 $572.87M
Total Assets Q2 2025 · Dec 31, 2024 $474.24M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 $0.02
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.11
Eps Basic Q2 2025 · Jun 30, 2024 −$0.15
Sga Expense Q2 2025 · Jun 30, 2025 $72.13M
Sga Expense Q2 2025 · Jun 30, 2025 $141.24M
Sga Expense Q2 2025 · Jun 30, 2024 $49.04M
Sga Expense Q2 2025 · Jun 30, 2024 $69.47M
Rd Expense Q2 2025 · Jun 30, 2025 $12.95M
Rd Expense Q2 2025 · Jun 30, 2025 $27M
Rd Expense Q2 2025 · Jun 30, 2024 $19.39M
Rd Expense Q2 2025 · Jun 30, 2024 $26.15M
Net Income Q2 2025 · Jun 30, 2025 $11.92M
Net Income Q2 2025 · Jun 30, 2025 −$4.4M
Net Income Q2 2025 · Mar 31, 2025 −$16.32M
Net Income Q2 2025 · Jun 30, 2024 −$70.84M
Net Income Q2 2025 · Jun 30, 2024 −$96.63M
Net Income Q2 2025 · Mar 31, 2024 −$25.79M
Operating Income Q2 2025 · Jun 30, 2025 $13.31M
Operating Income Q2 2025 · Jun 30, 2025 $2.99M
Operating Income Q2 2025 · Jun 30, 2024 −$68.42M
Operating Income Q2 2025 · Jun 30, 2024 −$95.62M
Revenue Q2 2025 · Jun 30, 2025 $103.14M
Revenue Q2 2025 · Jun 30, 2025 $179.39M
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0